Literature DB >> 6639911

Alpha thalassaemia and the macular vasculature in homozygous sickle cell disease.

P I Condon, R J Marsh, G H Maude, D R Higgs, D J Weatherall, G R Serjeant.   

Abstract

The interaction of homozygous alpha thalassaemia 2 with homozygous sickle cell (SS) disease results in a generally milder haematological picture with less intravascular sickling, less haemolysis, and higher haemoglobin levels. Clinically, patients are generally more mildly affected, though not all vaso-occlusive complications are reduced. Thus there is a possibility that the advantages gained by inhibition of sickling have been offset by the rheological disadvantages of the higher haemoglobin level. The capillary bed in the perimacular region of the posterior pole has been used to examine the degree of vaso-occlusion in age and sex matched controls with SS disease with and without homozygous alpha thalassaemia 2. The results demonstrated significantly less capillary abnormalities in the perimacular region of patients with alpha thalassaemia, though the size of the foveal avascular zone and the grading of perimacular capillary drop-out did not differ between the 2 genotypes. These results are compatible with a mild inhibitory effect of alpha thalassaemia on vaso-occlusion of the macular vasculature in SS disease.

Entities:  

Mesh:

Year:  1983        PMID: 6639911      PMCID: PMC1040198          DOI: 10.1136/bjo.67.11.779

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Macular and perimacular vascular remodelling sickling haemoglobinopathies.

Authors:  G K Asdourian; K C Nagpal; B Busse; M Goldbaum; D Patriankos; M F Rabb; M F Goldberg
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

2.  Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.

Authors:  S H Embury; A M Dozy; J Miller; J R Davis; K M Kleman; H Preisler; E Vichinsky; W N Lande; B H Lubin; Y W Kan; W C Mentzer
Journal:  N Engl J Med       Date:  1982-02-04       Impact factor: 91.245

3.  Macular vasculature, visual acuity, and irreversibly sickled cells in homozygous sickle cell disease.

Authors:  R J Marsh; S M Ford; M F Rabb; R J Hayes; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

4.  The interaction of alpha-thalassemia and homozygous sickle-cell disease.

Authors:  D R Higgs; B E Aldridge; J Lamb; J B Clegg; D J Weatherall; R J Hayes; Y Grandison; Y Lowrie; K P Mason; B E Serjeant; G R Serjeant
Journal:  N Engl J Med       Date:  1982-06-17       Impact factor: 91.245

  4 in total
  3 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

3.  Foveal avascular zone in macular branch retinal vein occlusion.

Authors:  M B Parodi; F Visintin; P Della Rupe; G Ravalico
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.